- Home
- HXHX vs CELZ Comparison
HXHX vs CELZ Comparison
Compare HXHX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HXHX | CELZ |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 6.4M |
| IPO Year | 2022 | 2008 |
Fundamental Metrics
Financial Performance| Metric | HXHX | CELZ |
|---|---|---|
| Price | $0.41 | $0.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 295.2K | 233.2K |
| Earning Date | 05-20-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.96 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.32 | $0.62 |
| 52 Week High | $1.67 | $6.25 |
Technical Indicators
Market Signals| Indicator | HXHX | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 42.61 | 47.52 |
| Support Level | $0.35 | $0.80 |
| Resistance Level | $0.56 | $1.15 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 16.09 | 52.14 |
Price Performance
Historical ComparisonAbout HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is a China-based logistics company engaged in temperature-controlled transportation and urban delivery services. The company provides cold chain logistics, freight forwarding, and related transportation services for goods, including new energy materials, electronic products, pharmaceuticals, meat, fruits, and vegetables. Its principal revenue streams are temperature-controlled truckload services and urban delivery services.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.